OOIR: Observatory of International Research

Papers

(The median citation count of Human Psychopharmacology-Clinical and Experimental is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Effects of lasmiditan on simulated driving performance: Results of two randomized, blinded, crossover studies with placebo and active controls	30
The rise of new psychoactive substances and psychiatric implications: A wide‐ranging, multifaceted challenge that needs far‐reaching common legislative strategies	27
Structured review of the use of the Arizona sexual experiences scale in clinical settings	19
A systematic review of (pre)clinical studies on the therapeutic potential and safety profile of kratom in humans	18
Psilocybin occasioned mystical‐type experiences	16
N,N‐dimethyltryptamine and Amazonian ayahuasca plant medicine	16
The effect of cannabidiol on simulated car driving performance: A randomised, double‐blind, placebo‐controlled, crossover, dose‐ranging clinical trial protocol	13
Efficacy of amisulpride for depressive symptoms in individuals with mental disorders: A systematic review and meta‐analysis	12
Comparison of potential psychiatric drug interactions in six drug interaction database programs: A replication study after 2 years of updates	11
Alpha7 nicotinic‐N‐methyl‐D‐aspartate hypothesis in the treatment of schizophrenia and beyond	11
Clinical predictors of depressive symptom remission and response after racemic ketamine and esketamine infusion in treatment‐resistant depression	11
Anabolic androgenic steroids used as performance and image enhancing drugs in professional and amateur athletes: Toxicological and psychopathological findings	10
Estimated model of psychotropic polypharmacy for bipolar disorder: Analysis using patients' and practitioners' parameters in the MUSUBI study	10
How does ayahuasca work from a psychiatric perspective? Pros and cons of the entheogenic therapy	10
Gabapentinoids for treatment of alcohol use disorder: A systematic review and meta‐analysis	10
Potential processes of change in MDMA‐Assisted therapy for social anxiety disorder: Enhanced memory reconsolidation, self‐transcendence, and therapeutic relationships	9
Sceletium tortuosum (Zembrin^®) ameliorates experimentally induced anxiety in healthy volunteers	9
Safety and cardiovascular effects of multiple‐dose administration of aripiprazole and olanzapine in a randomised clinical trial	9
Preliminary comparative analysis of kynurenine pathway metabolites in chronic ketamine users, schizophrenic patients, and healthy controls	8
A phase 1 double‐blind, placebo‐controlled study of zuranolone (SAGE‐217) in a phase advance model of insomnia in healthy adults	8
The effectiveness of long‐acting injectable antipsychotics versus oral antipsychotics in the maintenance treatment of outpatients with chronic schizophrenia	8
Coprescription of mood stabilizers in schizophrenia, dosing, and clinical correlates: An international study	8
Childhood maltreatment and clinical response to mood stabilizers in patients with bipolar disorder	8
Elevated serum levels of TNF‐α, IL‐6, and IL‐18 in chronic methamphetamine users	8
Clozapine‐induced agranulocytosis in Japan: Changes in leukocyte/neutrophil counts before and after discontinuation of clozapine	8

Efficacy of naltrexone in borderline personality disorder, a retrospective analysis in inpatients	8
Effect of crocin versus fluoxetine in treatment of mild to moderate obsessive‐compulsive disorder: A double blind randomized clinical trial	8
Effects of solriamfetol on on‐the‐road driving performance in participants with excessive daytime sleepiness associated with obstructive sleep apnoea	7
Progesterone loading as a strategy for treating postpartum depression	7
Inverse correlation between plasma 2‐arachidonoylglycerol levels and subjective severity of depression	7
Effectiveness, tolerability, and dropout rates of vortioxetine in comorbid depression: A naturalistic study	7
High‐dose Vitamin B6 supplementation reduces anxiety and strengthens visual surround suppression	7
Ayahuasca may help to improve self‐compassion and self‐criticism capacities	7
Effects of ayahuasca on the endocannabinoid system of healthy volunteers and in volunteers with social anxiety disorder: Results from two pilot, proof‐of‐concept, randomized, placebo‐controlled trials	7
Serotonin transporter availability, neurocognitive function and their correlation in abstinent 3,4‐methylenedioxymethamphetamine users	7
Restless Legs Syndrome among patients receiving antipsychotic and antidepressant drugs	6
Role of serotonin transporter and receptor gene polymorphisms in treatment response to selective serotonin reuptake inhibitors in major depressive disorder	6
How prevalent and severe is addiction on GABAmimetic drugs in an elderly German general hospital population? Focus on gabapentinoids, benzodiazepines, and z‐hypnotic drugs	5
The safety of agomelatine in standard medical practice in depressed patients: A 26‐week international multicentre cohort study	5
Treatment of depression: Are psychotropic drugs appropriately dosed in women and in the elderly? Dosages of psychotropic drugs by sex and age in routine clinical practice	5
Melatonin and melatonin‐agonists for metabolic syndrome components in patients treated with antipsychotics: A systematic review and meta‐analysis	5
Differential effects of different antipsychotic drugs on cognitive function in patients with chronic schizophrenia	5
Effect of venlafaxine dosage, valproic acid concentration, sex, and age on steady state dose‐corrected concentrations of venlafaxine and O‐desmethylvenlafaxine: A retrospective analy	5
Safety of switching to brexpiprazole in Japanese patients with schizophrenia: A post‐hoc analysis of a long‐term open‐label study	5
Correlation between pharmacokinetics and pharmacogenetics of Selective Serotonin Reuptake Inhibitors and Selective Serotonin and Noradrenaline Reuptake Inhibitors and maternal and neonatal outcomes: R	5
Drug‐induced tics: An observational postmarketing study	5
Duloxetine attenuates pain in association with downregulation of platelet serotonin transporter in patients with burning mouth syndrome and atypical odontalgia	4
Evaluation of memantine's efficacy and safety in the treatment of children with autism spectrum disorder: A systematic review and meta‐analysis	4
Inflammatory markers at baseline correlate with subsequent clinical response to quetiapine in patients with bipolar disorder	4
Effects of aripiprazole long‐acting injectable antipsychotic on hospitalization in recent‐onset schizophrenia	4
Effects of Korean red ginseng on human gray matter volume and cognitive function: A voxel‐based morphometry study	4
Effects ofPanax quinquefolius(American ginseng) on the steady state visually evoked potential during cognitive performance	4
Pharmacological treatment algorithms for the acute phase, agitation, and maintenance phase of first‐episode schizophrenia: Japanese Society of Clinical Neuropsychopharmacology treatment algorithms	4
The potential role of lysergic acid diethylamide for psychological assisted therapy: A meta‐analysis of randomised controlled trials in healthy volunteers	4
Influence of eight ABCB1 polymorphisms on antidepressant response in a prospective cohort of treatment‐free Russian patients with moderate or severe depression: An explorative psychopharmacological st	4
An explorative approach to understanding individual differences in driving performance and neurocognition in long‐term benzodiazepine users	4
Initiation of psychotropic medication in hospitalized patients with COVID‐19: Association with clinical and biological characteristics	4
Driving performance and neurocognitive skills of long‐term users of sedating antidepressants	3
Association of ANKK1 polymorphism with antipsychotic‐induced hyperprolactinemia	3
Adiponectin predicts poor response to antidepressant drugs in major depressive disorder	3
Systematic reviews of the acute effects of amphetamine on working memory and other cognitive performances in healthy individuals, with a focus on the potential influence of personality traits	3
The association between interleukin‐8 levels and the development of withdrawal symptoms during methamphetamine abstinence	3
Prospective analysis of serum prolactin levels, clinical symptomatology and sexual functions in patients with schizophrenia switched to paliperidone palmitate 3‐monthly from paliperidone palmitate 1‐m	3
Association between dopamine beta‐hydroxylase polymorphism and attention function in suicide attempters with chronic schizophrenia	2
The type 2 diabetes mellitus susceptibility gene CDKAL1 polymorphism is associated with depressive symptom in first‐episode drug‐naive schizophrenic patients	2
Efficacy of tiapride in the treatment of psychiatric disorders: A systematic review	2
Low‐dose ketamine infusion in treatment‐resistant double depression: Revisiting the adjunctive ketamine study of Taiwanese patients with treatment‐resistant depression	2
Plasma levels of interleukin‐8 and response to paroxetine in patients with major depressive disorder	2
Could N‐acetylcysteine improve the safety of clozapine?	2
Medication management of antipsychotic treatment in schizophrenia—A narrative review	2
Psychopharmacoepidemiology of antidepressant medications among homeless and unstably housed service users in the Veterans Affairs healthcare system	2
Influences on the use of antidepressants in primary care: All England general practice‐level analysis of demographic, practice‐level and prescriber factors	2
Does sodium oxybate inhibit brain dopamine release in humans? An exploratory neuroimaging study	2
Effects of solriamfetol on on‐the‐road driving in participants with narcolepsy: A randomised crossover trial	2
Comparison of naltrexone implant and oral buprenorphine‐naloxone in the treatment of opiate use disorder	2

Is short‐term antidepressant treatment effective and safe in bipolar depression? Results from an observational multicenter study	2
Relationship between suicide rate and antidepressant prescription: An ecological study in the People's Republic of China	2
Valproate‐associated hair abnormalities: Pathophysiology and management strategies	2
A reappraisal of acute doses of benzodiazepines as a model of anterograde amnesia	2
Nx4 attenuated stress‐induced activity of the anterior cingulate cortex—A post‐hoc analysis of a randomized placebo‐controlled crossover trial	2
Construct validity, sensitivity and specificity of the USCD Performance‐based Skill Assessment 2 in a mixed Portuguese sample	1
Stress, caffeine and psychosis‐like experiences—A double‐blind, placebo‐controlled experiment	1
A diffusion tensor imaging study in schizophrenia patients with clozapine induced obsessive compulsive symptoms	1
Renal effects of long‐term lithium therapy, revisited	1
J Guy Edwards, FRCPsych, FRCP, FRCGP (Hon), DPM, HonMFPH, Founding Editor of Human Psychopharmacology	1
The chemical induction of synaesthesia	1
Blinding and bias in a hypnotic clinical trial	1
Facilitated extinction of conditioned fear responses by delta 9‐tetrahyrdrocannabidol in humans: a pilot study	1
The first patient to receive olanzapine: A recollection	1
Response efficacy and heterogeneity of antipsychotic drugs in schizophrenia: Systemic review and meta‐analysis	1
Efficacy of the nootropic supplement Mind Lab Pro on memory in adults: Double blind, placebo‐controlled study	1
Efficacy and safety of hydroxyzine for sleep in adults: Systematic review	1
Acute caffeine intake in humans reduces post exercise performance in learning and memory	1
The antimuscarinic agent biperiden selectively impairs recognition of abstract figures without affecting the processing of non‐words	1
Reproductive health in an inpatient psychiatric unit: A retrospective chart review	1
Dexamphetamine influences funneling illusion based on psychometric score	1
A narrative review of the neuropharmacology of synthetic cathinones—Popular alternatives to classical drugs of abuse	1
Lithium in bipolar depression: A review of the evidence	1
Association of serotonin transporter gene polymorphism with efficacy of the antidepressant drugs sertraline and mirtazapine in newly diagnosed patients with major depressive disorders	1
5‐MeO‐DMT has not been found in traditional ayahuasca preparations and the combination of 5‐MeO‐DMT with MAOIs is dangerous	1
Resting state functional connectivity in adolescent synthetic cannabinoid users with and without attention‐deficit/hyperactivity disorder	1
Serum levels of neuropeptide Y in patients with chronic schizophrenia during treatment augmentation with sarcosine (results of the double‐blind randomized controlled PULSAR study)	1
Estradiol treatment in young postmenopausal women with self‐reported cognitive complaints: Effects on cholinergic‐mediated cognitive performance	1
A pilot study assessing the brain gauge as an indicator of cognitive recovery in alcohol dependence	1
Can placebo or nocebo pills improve or impair cognition performance?	1
Effect of necessity‐concern framework and polypharmacy on treatment adherence in psychiatric patients. Comparing an Argentinian with a Spanish sample	1